ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR‐ABL is the molecular hallmark of CML with tyrosine kinase activity that can potentially activate multiple signal transduction pathways, resulting in abnormal cell proliferation, apoptosis, migration, invasion and differentiation.13, 14, 15